Research sites & clinicians
Conversations that begin in the right place.
People reach you with the study understood, fit considered, and readiness in view, so the first conversation starts well.
What arrives at your door
Better-prepared people, with context.
- People arrive having met a plain-language summary with medifit™ + readifit™ self-reflection tools.
- They have understood the study and considered how it fits their life.
- You receive a structured view of where they are, rather than discovering it during screening.
Additive to what already works
Less friction, not more.
Starting with a structured view of understanding and readiness surfaces concerns earlier and reduces misunderstandings that only show up later as a dropout. Eligibility screening and informed consent continue at your site, led by your team. trialport does not screen, enrol, or consent participants.
Common questions
For research sites and clinicians.
Does this replace our screening process?
No. All screening and eligibility decisions remain with the research site.
What information does a site receive?
Contact details and engagement context, only when a person chooses to connect and provides consent.
Will this increase our workload?
The goal is the opposite: fewer low-quality enquiries and fewer repetitive early-stage conversations.
Is there a cost to receive enquiries?
No. Research sites are not charged to receive patient enquiries through trialport.